Published in Medicine and Law Weekly, July 7th, 2006
These two newly issued patents are for methods of signaling the heart, which improve the function of implanted cardiovascular devices. The first, U.S. Patent 7,020,517, teaches a means of detecting and responding in a manner that avoids the onset of ventricular fibrillation, the heart rhythm that causes sudden death. The method uses a low voltage electrical signal, which can be built into a low cost pacemaker and provide some protection against fibrillation events.
The...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.